Thijs Veerman
CEO
Catherinn BV
Leiden, Netherlands
1 profile visit
Catherinn develops immunotherapy and diagnostic solutions for Small Cell Lung Cancer patients with our proprietary NCAM180 biomarker
My organisation
At Catherinn BV, we are dedicated to delivering innovative solutions that empower businesses to thrive in a competitive marketplace. Our team collaborates closely with clients to understand their unique challenges, offering tailored services that drive efficiency and growth. With a focus on sustainability and technology integration, we strive to create lasting partnerships that foster success for everyone involved. Join us as we navigate the future of business together, leveraging our expertise to unlock new opportunities.
About me
former CEO Netherlands Vaccine Institute
currently: CEO Catherinn and advisor to INFECTA (www.infecta.org)